Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis

Journal of Dermatological Science

Volumn 66, Issue 1, 2012, Pages 60-63

  Furue, Masutaka ^a   Matsumoto, Tsuyoshi ^b   Yamamoto, Tetsuo ^c   Takeuchi, Satoshi ^a   Esaki, Hitokazu ^a   Chiba, Takahito ^a   Yamaguchi, Hideyo ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b POLA CHEMICAL INDUSTRIES INC   (Japan)

^c TTC Co Ltd   (Japan)

Author keywords

Atopic dermatitis; Skin barrier; Stratum corneum hydration; Thymus and activation regulated chemokine; Transepidermal water loss

Indexed keywords

CORTICOSTEROID; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; EPIDERMIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN PERMEABILITY; SKIN WATER LOSS; STRATUM CORNEUM;

ADULT; BIOLOGICAL MARKERS; CHEMOKINE CCL17; DERMATITIS, ATOPIC; EPIDERMIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERMEABILITY; SEVERITY OF ILLNESS INDEX; WATER LOSS, INSENSIBLE; YOUNG ADULT;

EID: 84862798346     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.01.011     Document Type: Article

References (30)

1. Hanifin J.M. Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. J Invest Dermatol 2009, 129:320-322.
2. Elias P.M., Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009, 9:437-446.
3. Barnes K.C. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 2010, 125:16-29.
4. Niebuhr M., Werfel T. Innate immunity, allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2010, 10:463-468.
5. Jakasa I., Koster E.S., Calkoen F., McLean W.H., Campbell L.E., Bos J.D., et al. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol 2011, 131:540-542.
6. Casper K.A., Mehta B.H. Healthy skin for women: a review of common conditions and therapies. J Am Pharm Assoc (Wash) 2002, 42:206-215.
7. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001, 107:535-541.
8. Hijnen D., De Bruin-Weller M., Oosting B., Lebre C., De Jong E., Bruijnzeel-Koomen C., et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004, 113:334-340.
9. Jahnz-Rozyk K., Targowski T., Paluchowska E., Owczarek W., Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005, 60:685-688.
10. Tamaki K., Kakinuma T., Saeki H., Horikawa T., Kataoka Y., Fujisawa T., et al. Serum levels of CCL 17/TARC in various skin diseases. J Dermatol 2006, 33:300-302.
11. Tamaki K., Saeki H., Kadono T., Sato S., Yata N., Hasegawa M., et al. Serum TARC/CCL 17 levels as disease marker of atopic dermatitis. Jpn J Dermatol 2006, 116:27-39.
12. Werner Y., Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol (Stockh) 1985, 65:102-105.
13. Werner Y., Lindberg M., Forslind B. The water-binding capacity of stratum corneum in dry non-eczematous skin of atopic eczema. Acta Derm Venereol (Stockh) 1982, 62:334-337.
14. Watanabe M., Tagami H., Horii I., Takahashi M., Kligman A.M. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol 1991, 127:1689-1692.
15. Tagami H., Kobayashi H., O'goshi K., Kikuchi K. Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products. J Cosmet Dermatol 2006, 5:140-149.
16. Saeki H., Furue M., Furukawa F., Hide M., Ohtsuki M., Katayama I., et al. Guidelines for management of atopic dermatitis. J Dermatol 2009, 36:563-577.
17. Tagami H., Ohi M., Iwatsuki K., Kanamaru Y., Yamada M., Ichijo B. Evaluation of the skin surface hydration in vivo by electrical measurement. J Invest Dermatol 1980, 75:500-507.
18. Leung T.F., Ma K.C., Hon K.L., Lam C.W., Wan H., Li C.Y., et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 2003, 14:296-301.
19. Seidenari S., Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995, 75:429-433.
20. Chamlin S.L., Kao J., Frieden I.J., Sheu M.Y., Fowler A.J., Fluhr J.W., et al. Ceramide-dominant barrier repair lipids alleviate child hood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002, 47:198-208.
21. Sugarman J.L., Fluhr J.W., Fowler A.J., Bruckner T., Diepgen T.L., Williams M.L. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003, 139:1417-1422.
22. Imai T., Yoshida T., Baba M., Nishimura M., Kakizaki M., Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996, 271:21514-21521.
23. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998, 28:2760-2769.
24. Hashimoto S., Suzuki T., Dong H.Y., Nagai S., Yamazaki N., Matsushima K. Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 1999, 94:845-852.
25. Sallusto F., Palermo B., Lenig D., Miettinen M., Matikainen S., Julkunen I., et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999, 29:1617-1625.
26. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999, 104:1097-1105.
27. Morita E., Takahashi H., Niihara H., Dekio I., Sumikawa Y., Murakami Y., et al. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. Allergy 2010, 65:1166-1172.
28. Werner Y. The water content of the stratum corneum in patients with atopic dermatitis. Measurement with the Corneometer CM420. Acta Derm Venereol (Stockh) 1986, 66:281-284.
29. Uehara M., Miyauchi H. The morphologic characteristics of dry skin in atopic dermatitis. Arch Dermatol 1984, 120:1186-1190.
30. Miyamoto K., Inoue Y., Hsueh K., Liang Z., Yan X., Yoshii T., et al. Characterization of comprehensive appearances of skin ageing: an 11-year longitudinal study on facial skin ageing in Japanese females at Akita. J Dermatol Sci 2011, 64:229-236.